Clecell Co., Ltd. produces and commercializes 3D human tissues in the fields of regenerative medicine and precision medicine using the original 3D bioprinting technology created by a team of Harvard Medical School researchers. The company's mission is to create revolutionary healthcare solutions by fabricating artificial tissues with complex structures and functionalities using biomaterials and tissues.Clecell is investigating applications in a variety of sectors, including printing patient-specific organs and tissues, printing tissue models to test drug effects, tissue regeneration and repair, and molecular and cell biology research. Clecell's goal is to create breakthrough technologies and solutions that will promote development and progress in the sectors of life sciences, healthcare, and regenerative medicine.
2020
-
03
Completion of 3D Bioprinter(U-FAB) Development
-
06
Completion of 3D artificial skin (U-AskinTM) protocol
-
08
Joint research agreement for 3D atopic skin model and atopic treatment screening kit with Korea University Technology Holdings
-
09
Provision of U FAB 3D bioprinter to Harvard Medical School for joint research
2019
-
05
Set up Boston Bioprinting Consortium(BBC) composed of doctors and professors in Boston, USA
-
05
Set up Boston Bioprinting Consortium(BBC) composed of doctors and professors in Boston, USA
-
05
Venture company certified
2018
-
01
Transfer of Patent from Harvard medical school
-
01
KOTRA 2018 KOREA-FRANCE Startup Summit Participating Company Selected by KOTRA
-
11
Sponsored Research Agreement with Brigham and Women’s Hospital (Teaching hospital of Harvard University)
-
11
Set up corporate affiliated research center
2016
-
12
Company Incorporated
3D Bioprinters
U-FAB, a representative 3D bioprinter manufactured by Clecell Co., Ltd., is capable of printing with up to 15 nozzles and is capable of printing a variety of polymers and bioinks from low to high viscosity. In addition, it is possible to print elaborate 3D structures by controlling the temperature of the build-plate, cross-linking using a multi-channel nebulizer, and using a filament extruder. Clecell's 3D bio printer maximizes productivity by enabling simultaneous multi-channel printing.
Bioinks
Celluid GM and Celluid AM are available as sponge type bioinks(solid), with the advantage of the ability to mix and match the viscosity of the bioinks and photoinitiator to suit the research purpose.
Skin Cells
We established a protocol to differentiate human induced pluripotent stem cells (hiPSC) into skin cells, fibroblasts and keratinocytes, and commercialized human induced pluripotent stem cell-derived fibroblasts and keratinocytes in order to secure stable human fibroblasts and keratinocytes, which are crucial raw materials for the production of artificial skin.
Artificial Skin
Artificial skin is a skin replica manufactured from human skin cells and skin-related materials like collagen, and as it is composed of living skin cells, it resembles actual skin in both shape and response. Animal testing can be replaced by the use of artificial skin in cosmetics, medicine toxicity and efficacy tests, skin studies, etc.
-
Tissue Engineering
The use of tissue engineering offers the chance to miraculously regenerate human tissue and replenish lost tissue in the body. One of the main objectives of tissue engineering is to enable the repair and regeneration of damaged tissues. Cleasel's Celluid bioinks series also intends to further create customizable scaffolding for printing tissues or organs.
-
Organoids
An organoid is a three-dimensional organic matter system that has been artificially manufactured. Organoid research has a variety of uses in the areas of tissue engineering, disease research, and drug development.
-
hiPSCs
Induced pluripotent stem cells have a variety of gene expressions that can be used to study patient-specific gene traits. Our research team is working on developing artificial skin models using induced pluripotent stem cells.
-
Address.
201-204 of Munjeong Daemyung Bellion, 127 Beopwon-ro, Songpa-gu, Seoul, KR
-
Tel.
+82 2-6951-3100
-
Fax.
+82 2-6951-3150
-
E-mail.
clecell@clecell.co.kr
